These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18824097)

  • 1. Lipid nanoparticles for parenteral delivery of actives.
    Joshi MD; Müller RH
    Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J; Hommoss A; Müller RH
    Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
    Souto EB; Müller RH
    Int J Cosmet Sci; 2008 Jun; 30(3):157-65. PubMed ID: 18452432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
    Müller RH; Petersen RD; Hommoss A; Pardeike J
    Adv Drug Deliv Rev; 2007 Jul; 59(6):522-30. PubMed ID: 17602783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
    J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles for improved topical application of drugs for skin diseases.
    Schäfer-Korting M; Mehnert W; Korting HC
    Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
    Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
    Bunjes H
    J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carriers system: recent advances in drug delivery.
    Iqbal MA; Md S; Sahni JK; Baboota S; Dang S; Ali J
    J Drug Target; 2012 Dec; 20(10):813-30. PubMed ID: 22931500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.